Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cytarabine
100%
Leukemia Cells
100%
Apoptosis Induction
100%
Bone Marrow Stromal Cells
100%
Equilibrative nucleoside Transporter
30%
Chemoprotection
30%
Bone Marrow Stroma
30%
Acute Myeloid Leukemia
20%
Bone Marrow
20%
Soluble Factors
20%
Bone Marrow Microenvironment
20%
Cytotoxic Agents
20%
Mouse Model
10%
Prolonged Survival
10%
Chemotherapy
10%
Survival Benefit
10%
Flow Cytometry
10%
Adenosine
10%
Cell Apoptosis
10%
Peripheral Blood
10%
Cell Mobilization
10%
Western Blotting
10%
Conventional Chemotherapy
10%
Tumor Microenvironment
10%
5-fluorouracil (5-FU)
10%
Intracellular Accumulation
10%
Drug Resistance
10%
Leukemia Model
10%
Chemosensitization
10%
Residual Disease
10%
Human Leukemia Cell Line
10%
High Response Rate
10%
CXCR4 Inhibitor
10%
Etoposide-cisplatin
10%
Cancer Cell Survival
10%
Leukemia Mice
10%
Chemoprotective Effect
10%
Cell Incorporation
10%
Cells Supernatant
10%
Mouse Leukemia
10%
Immunology and Microbiology
Leukemia Cell
100%
Programmed Cell Death
100%
Stroma
30%
Myeloid
20%
Bone Marrow Microenvironment
20%
In Vitro
20%
Mouse Model
10%
Drug Resistance
10%
Cell Survival
10%
Cancer Cell
10%
Western Blot
10%
Supernatant
10%
CXCR4
10%
Sensitization
10%
Leukemia Cell Line
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cytarabine
100%
Leukemia
100%
Equilibrative Nucleoside Transporter 1
25%
Acute Myeloid Leukemia
16%
Chemotherapy Regimens
16%
Cytotoxic Agent
16%
Malignant Neoplasm
8%
Mouse Model
8%
Adenosine
8%
Western Blot
8%
Cisplatin
8%
Flow Cytometry
8%
Tumor Microenvironment
8%
Drug Resistance
8%
Etoposide
8%
Minimal Residual Disease
8%
Fluorouracil
8%
Murine Leukemia
8%